A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia

Neuropathology and Applied Neurobiology

Volumn 40, Issue 2, 2014, Pages 177-190

  Bandopadhyay, R ^a   Liu, J Y W ^a   Sisodiya, S M ^a   Thom, M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Dementia; Dentate gyrus; Epilepsy; Hippocampal sclerosis; Hirano bodies; Synaptic reorganization

Indexed keywords

CALBINDIN; CALRETININ; DYNORPHIN; NEUROPEPTIDE Y;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; COMPARATIVE STUDY; DENTATE GYRUS; EPILEPSY; FEMALE; FIBER; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOSSY FIBER; PRIORITY JOURNAL;

DEMENTIA; DENTATE GYRUS; EPILEPSY; HIPPOCAMPAL SCLEROSIS; HIRANO BODIES; SYNAPTIC REORGANIZATION;

AGED; ALZHEIMER DISEASE; DEMENTIA; DENTATE GYRUS; EPILEPSY; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMANS; MALE; SCLEROSIS;

EID: 84892654547     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12087     Document Type: Article

References (61)

1. Blumcke I, Coras R, Miyata H, Ozkara C. Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Pathol 2012; 22: 402-411
2. Labate A, Gambardella A, Andermann E, Aguglia U, Cendes F, Berkovic SF, Andermann F. Benign mesial temporal lobe epilepsy. Nature reviews. Neurology 2011; 7: 237-240
3. Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, Baulac M. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256-1262
4. Bonilha L, Martz GU, Glazier SS, Edwards JC. Subtypes of medial temporal lobe epilepsy: influence on temporal lobectomy outcomes? Epilepsia 2012; 53: 1-6
5. Thom M, Liu JY, Thompson P, Phadke R, Narkiewicz M, Martinian L, Marsdon D, Koepp M, Caboclo L, Catarino CB, Sisodiya SM. Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. Brain 2011; 134: 2969-2981
6. Thom M. Hippocampal sclerosis: progress since Sommer. Brain Pathol 2009; 19: 565-572
7. Houser CR. Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res 1990; 535: 195-204
8. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989; 26: 321-330
9. Magloczky Z. Sprouting in human temporal lobe epilepsy: excitatory pathways and axons of interneurons. Epilepsy Res 2010; 89: 52-59
10. Magloczky Z, Halasz P, Vajda J, Czirjak S, Freund TF. Loss of calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 1997; 76: 377-385
11. Magloczky Z, Wittner L, Borhegyi Z, Halasz P, Vajda J, Czirjak S, Freund TF. Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience 2000; 96: 7-25
12. Martinian L, Catarino CB, Thompson P, Sisodiya SM, Thom M. Calbindin D28K expression in relation to granule cell dispersion, mossy fibre sprouting and memory impairment in hippocampal sclerosis: a surgical and post mortem series. Epilepsy Res 2012; 98: 14-24
13. Mathern GW, Babb TL, Pretorius JK, Leite JP. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 1995; 15: 3990-4004
14. Thom M, Liagkouras I, Martinian L, Liu J, Catarino CB, Sisodiya SM. Variability of sclerosis along the longitudinal hippocampal axis in epilepsy: a post mortem study. Epilepsy Res 2012; 102: 45-59
15. Probst A, Taylor KI, Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol 2007; 114: 335-345
16. Zarow C, Sitzer TE, Chui HC. Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr Neurol Neurosci Rep 2008; 8: 363-370
17. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, Van Eldik LJ, Kryscio RJ. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011; 134: 1506-1518
18. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or=80 years of age) humans. Acta Neuropathol 1994; 88: 212-221
19. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11
20. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011; 122: 111-113
21. Liu JY, Martinian L, Thom M, Sisodiya SM. Immunolabeling recovery in archival, post-mortem, human brain tissue using modified antigen retrieval and the catalyzed signal amplification system. J Neurosci Methods 2010; 190: 49-56
22. Liu JY, Thom M, Catarino CB, Martinian L, Figarella-Branger D, Bartolomei F, Koepp M, Sisodiya SM. Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy. Brain 2012; 135: 3115-3133
23. Thom M, Martinian L, Catarino C, Yogarajah M, Koepp MJ, Caboclo L, Sisodiya SM. Bilateral reorganization of the dentate gyrus in hippocampal sclerosis: a postmortem study. Neurology 2009; 73: 1033-1040
24. Miyata H, Hori T, Vinters HV. Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia. Neuropathology 2013; 33: 442-458
25. Martinian L, Boer K, Middeldorp J, Hol EM, Sisodiya SM, Squier W, Aronica E, Thom M. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Neuropathol Appl Neurobiol 2009; 35: 394-405
26. Zarow C, Weiner MW, Ellis WG, Chui HC. Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav 2012; 2: 435-442
27. Blumcke I, Kistner I, Clusmann H, Schramm J, Becker AJ, Elger CE, Bien CG, Merschhemke M, Meencke HJ, Lehmann T, Buchfelder M, Weigel D, Buslei R, Stefan H, Pauli E, Hildebrandt M. Towards a clinico-pathological classification of granule cell dispersion in human mesial temporal lobe epilepsies. Acta Neuropathol 2009; 117: 535-544
28. Wieser HG. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004; 45: 695-714
29. Thom M, Liagkouras I, Elliot KJ, Martinian L, Harkness W, McEvoy A, Caboclo LO, Sisodiya SM. Reliability of patterns of hippocampal sclerosis as predictors of postsurgical outcome. Epilepsia 2010; 51: 1801-1808
30. Blumcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger C, Merschhemke M, Meencke HJ, Lehmann T, von Deimling A, Scheiwe C, Zentner J, Volk B, Romstock J, Stefan H, Hildebrandt M. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol 2007; 113: 235-244
31. de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid T, Spencer DD. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 2003; 44: 677-687
32. Gaitatzis A, Sisodiya SM, Sander JW. The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 2012; 53: 1282-1293
33. Pandis D, Scarmeas N. Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr 2012; 12: 184-187
34. Greenfield JG, Love S, Louis DN, Ellison D. Greenfield's Neuropathology, 8th edn. London: Hodder Arnold, 2008
35. Chan-Palay V, Lang W, Haesler U, Kohler C, Yasargil G. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia. J Comp Neurol 1986; 248: 376-394
36. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007; 55: 697-711
37. Dumas TC, Powers EC, Tarapore PE, Sapolsky RM. Overexpression of calbindin D(28k) in dentate gyrus granule cells alters mossy fiber presynaptic function and impairs hippocampal-dependent memory. Hippocampus 2004; 14: 701-709
38. Jouvenceau A, Potier B, Poindessous-Jazat F, Dutar P, Slama A, Epelbaum J, Billard JM. Decrease in calbindin content significantly alters LTP but not NMDA receptor and calcium channel properties. Neuropharmacology 2002; 42: 444-458
39. Odero GL, Oikawa K, Glazner KA, Schapansky J, Grossman D, Thiessen JD, Motnenko A, Ge N, Martin M, Glazner GW, Albensi BC. Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease. Neuroscience 2010; 169: 532-543
40. Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, Masliah E, Mucke L. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 2003; 100: 9572-9577
41. Moreno H, Burghardt NS, Vela-Duarte D, Masciotti J, Hua F, Fenton AA, Schwaller B, Small SA. The absence of the calcium-buffering protein calbindin is associated with faster age-related decline in hippocampal metabolism. Hippocampus 2012; 22: 1107-1120
42. Bouilleret V, Schwaller B, Schurmans S, Celio MR, Fritschy JM. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 2000; 97: 47-58
43. Popovic M, Caballero-Bleda M, Kadish I, Van Groen T. Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice. Neuroscience 2008; 155: 182-191
44. Takahashi H, Brasnjevic I, Rutten BP, Van Der Kolk N, Perl DP, Bouras C, Steinbusch HW, Schmitz C, Hof PR, Dickstein DL. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease. Brain Struct Funct 2010; 214: 145-160
45. Ferrer I. Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord 1999; 10 (Suppl. 1): 55-60
46. Corrada MM, Berlau DJ, Kawas CH. A population-based clinicopathological study in the oldest-old: the 90+ study. Curr Alzheimer Res 2012; 9: 709-717
47. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 2011; 25: 364-368
48. Peterson C, Kress Y, Vallee R, Goldman JE. High molecular weight microtubule-associated proteins bind to actin lattices (Hirano bodies). Acta Neuropathol 1988; 77: 168-174
49. Myre MA. Clues to gamma-secretase, huntingtin and Hirano body normal function using the model organism Dictyostelium discoideum. J Biomed Sci 2012; 19: 41
50. Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathol 2011; 122: 285-292
51. Somogyi P, Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol 2005; 562: 9-26
52. Maccaferri G. Stratum oriens horizontal interneurone diversity and hippocampal network dynamics. J Physiol 2005; 562: 73-80
53. Szilagyi T, Orban-Kis K, Horvath E, Metz J, Pap Z, Pavai Z. Morphological identification of neuron types in the rat hippocampus. Rom J Morphol Embryol 2011; 52: 15-20
54. Decressac M, Barker RA. Neuropeptide Y and its role in CNS disease and repair. Exp Neurol 2012; 238: 265-272
55. Ramos B, Baglietto-Vargas D, del Rio JC, Moreno-Gonzalez I, Santa-Maria C, Jimenez S, Caballero C, Lopez-Tellez JF, Khan ZU, Ruano D, Gutierrez A, Vitorica J. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiol Aging 2006; 27: 1658-1672
56. Long L, Xiao B, Feng L, Yi F, Li G, Li S, Mutasem MA, Chen S, Bi F, Li Y. Selective loss and axonal sprouting of GABAergic interneurons in the sclerotic hippocampus induced by LiCl-pilocarpine. Int J Neurosci 2011; 121: 69-85
57. Aronica E, Dickson DW, Kress Y, Morrison JH, Zukin RS. Non-plaque dystrophic dendrites in Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry. Neuroscience 1998; 82: 979-991
58. Furgerson M, Fechheimer M, Furukawa R. Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain. Plos ONE 2012; 7: e44996
59. King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 2010; 30: 408-419
60. Kauffman MA, Consalvo D, Moron DG, Lereis VP, Kochen S. ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis. Epilepsy Res 2010; 90: 234-239
61. Yeni SN, Ozkara C, Buyru N, Baykara O, Hanoglu L, Karaagac N, Ozyurt E, Uzan M. Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol 2005; 12: 103-107